Sarah Kilpatrick, MD, PhD, discusses the goal of gender equity in health research to prevent women from being misdiagnosed, overprescribed, or otherwise harmed by a medical system that has been designed predominantly around the male body.
Can precision medicine help solve the problem of inadequate diversity in medical research? The practice of precision medicine may contain its own solution: Technology has made it easier than ever to tap into the complexity of all humankind.
Mysteries surrounding cancer genomics have been stripped away in recent years, exposing the disease as a target for precision medicine. Monica Mita, MD, co-director of Experimental Therapeutics at Cedars-Sinai, explains how oncology research stands to gain ground in the near future.
No single person, institution, or nation is as smart as all of us thinking together. That is the driving principle behind an ambitious research collaboration that could lead to more effective cancer treatments. Cedars-Sinai has combined forces with the Translational Read On
Why early detection is so important to fighting Alzheimer’s—and how a simple eye test may be the solution. Read On
Before they can be approved and marketed, experimental therapies must complete the clinical trial journey, during which it is determined if a therapy is safe and effective. Clinical trials are conducted in phases during which key questions are addressed. The clinical trial process usually entails considerable hurdles. Clinical trials take an average of eight years to complete, cost thousands of dollars for each participant, and often struggle to recruit enough participants. The majority of studies will not reach their ultimate destination. But those that do represent true advances in medicine.